Assessment of the Efficacy of Certolizumab Pegol in the Maintenance of Response for the Treatment of Crohn's Disease

被引：0
|
作者：
Lee, Scott D.
Ko, Cynthia W.
Wahbeh, Ghassan
Cullinan, Cory
Etter, Scott
Sinanan, Mika N.
Wheat, Chelle
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S282 / S282
页数：1
相关论文
共 50 条
  • [41] COST UTILITY ANALYSIS OF CERTOLIZUMAB PEGOL VERSUS NATALIZUMB MAINTENANCE THERAPY FOR CROHN'S DISEASE
    Wu, B.
    VALUE IN HEALTH, 2010, 13 (03) : A73 - A73
  • [42] Clinical trial: impact of prior infliximab therapy on the clinical response to certolizumab pegol maintenance therapy for Crohn's disease
    Hanauer, S. B.
    Panes, J.
    Colombel, J. -F.
    Bloomfield, R.
    Schreiber, S.
    Sandborn, W. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (03) : 384 - 393
  • [43] Estimation of induction and maintenance costs of Infliximab, Adalimumab and Certolizumab Pegol in managing Crohn's Disease
    Feagan, B.
    Tan, S.
    Malone, D.
    Hinojosa, J.
    Brown, M.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S33 - S33
  • [44] A Clinical Prediction Model to Determine Probability of Response to Certolizumab Pegol for Crohn's Disease
    Lefevre, Pavine L. C.
    Dulai, Parambir S.
    Wang, Zhongya
    Guizzetti, Leonardo
    Feagan, Brian G.
    Pop, Anca
    Yassine, Mohamed
    Shackelton, Lisa M.
    Jairath, Vipul
    Sandborn, William J.
    Vande Casteele, Niels
    BIODRUGS, 2022, 36 (01) : 85 - 93
  • [45] A Clinical Prediction Model to Determine Probability of Response to Certolizumab Pegol for Crohn’s Disease
    Pavine L. C. Lefevre
    Parambir S. Dulai
    Zhongya Wang
    Leonardo Guizzetti
    Brian G. Feagan
    Anca Pop
    Mohamed Yassine
    Lisa M. Shackelton
    Vipul Jairath
    William J. Sandborn
    Niels Vande Casteele
    BioDrugs, 2022, 36 : 85 - 93
  • [46] Severe Crohn's disease symptoms are relieved by certolizumab pegol
    Feagan, Brian G.
    Coteur, Geoffroy
    Keininger, Doroth L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S471 - S471
  • [47] Certolizumab pegol: A guide to its use in Crohn's disease
    不详
    Drugs & Therapy Perspectives, 2007, 23 (11) : 5 - 8
  • [48] CERTOLIZUMAB PEGOL IN CROHN'S DISEASE REFRACTORY TO INFLIXIMAB AND ADALIMUMAB
    Jose, Morales Lara Ma
    Penella Monica, Martinez
    Guzman Diana, Lacruz
    Vidal Vanessa, Jorge
    Maneiro Vicente, Santaclara
    Sanchez Senador, Moran
    del Carmen, Mira Sirvent Ma
    ATENCION FARMACEUTICA, 2009, 11 (03): : 178 - 180
  • [49] Efficacy of Certolizumab Pegol in Preoperative Management of Ileal Crohn's Strictures
    Randall, Charles
    Ramos, Raul
    Taboada, Carlo
    Fincke, Christopher
    Havranek, Russell
    Zurita, Franz
    Stump, David
    Gossen, Gary
    Martinez, Armando
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S433 - S433
  • [50] Oral lichen planus after certolizumab pegol treatment in a patient with Crohn's disease
    Mocciaro, Filippo
    Orlando, Ambrogio
    Renna, Sara
    Rizzuto, Maria Rosa
    Cottone, Mario
    JOURNAL OF CROHNS & COLITIS, 2011, 5 (02): : 173 - 174
12345